Use of EtCO2 as a PaCO2 Predictor Under Non Invasive Ventilation (NIV) in Cases of Acute Hypercapnic Respiratory Failure
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01489150 |
Recruitment Status
:
Completed
First Posted
: December 9, 2011
Last Update Posted
: May 16, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hypercapnic Respiratory Failure |
Study Type : | Observational |
Actual Enrollment : | 11 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Use of EtCO2 and Prolonged Expiratory Maneuvers as a PaCO2 Predictor in Cases of Acute Hypercapnic Respiratory Failure |
Study Start Date : | December 2011 |
Actual Primary Completion Date : | April 2012 |
Actual Study Completion Date : | December 2012 |

- Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration [ Time Frame: Sixty minutes ]Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- ICU patient equipped with arterial line
- NIV requirement
- Hypercapnia: PaCO2 > 45mmhg
Exclusion Criteria:
- Severe hemodynamic instability
- Severe psychiatric disorders
- nasal lesions
- denied consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01489150
Switzerland | |
Intensive care and burn unit, University Hospital of Lausanne | |
Lausanne, Switzerland, 1011 |
Principal Investigator: | Philippe Jolliet, Professor | University of Lausanne Hospitals |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Prof. Philippe Jolliet, Principal investigator, University of Lausanne Hospitals |
ClinicalTrials.gov Identifier: | NCT01489150 History of Changes |
Other Study ID Numbers: |
EtCO2-NIV |
First Posted: | December 9, 2011 Key Record Dates |
Last Update Posted: | May 16, 2013 |
Last Verified: | May 2013 |
Keywords provided by Prof. Philippe Jolliet, University of Lausanne Hospitals:
Acute respiratory failure Hypercapnia Non invasive ventilation End-tidal CO2 |
Additional relevant MeSH terms:
Respiratory Insufficiency Hypercapnia Respiration Disorders |
Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |